However, analysis of the co-expression of OBR mRNA and additional leptin-targeted genes (MYC, CD44, and ZEB1) using TCGA breast cancer patient datasets did not show association with changes in survival either in BCER+ or BCER− patients. This evidence concerns the gene CD44 and breast carcinoma.